Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FREMANEZUMAB-VFRM vs FULVESTRANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FREMANEZUMAB-VFRM vs FULVESTRANT: Safety Overview

Metric FREMANEZUMAB-VFRM FULVESTRANT
Total FAERS Reports 9,103 17,675
Deaths Reported 74 3,087
Death Rate 0.8% 17.5%
Hospitalizations 558 4,103
Average Patient Age 49.5 yrs 63.0 yrs
% Female Patients 89.2% 99.0%
FDA Approval Date N/A Apr 25, 2002
Manufacturer N/A BluePoint Laboratories
Route N/A INTRAMUSCULAR
Marketing Status Prescription Prescription